Background illustration for clinical trials search

Bristol Myers Squibb Clinical Trials

Find clinical trials for Bristol Myers Squibb. Search for Bristol Myers Squibb clinical trials in different cities and states across the United States.

Filter

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, New York NY, Hackensack NJ, Buffalo NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06121843

Phase 1, Recruiting

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Halifax, Boston MA, New York NY, Montreal,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06615479

Phase 3, Recruiting

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: Markham, Toronto, Edmonton
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 4 - 18

Code: NCT04772079

Phase 3, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Hackensack NJ, Montreal, Toronto, Vancouver,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06476808

Phase 1, Recruiting

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

for
Psoriasis
Location: Waltham MA
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05744466

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting

for
Follicular Lymphoma
Location: Milwaukee WI
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06794268

Recruiting

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

for
Non-small Cell Lung Cancer
Location: New York NY, Lancaster PA, Greenville NC, Syracuse NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06561386

Phase 3, Recruiting

A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring

for
Multiple Sclerosis
Location: Bethesda MD
Sponsor: Bristol-Myers Squibb

Sex: Female

Age: 0+

Code: NCT05170126

Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, New York NY, New Brunswick NJ, Montreal,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase 2, Recruiting

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

for
Relapsed/Refractory Non-Hodgkin Lymphoma
Location: Boston MA, New York NY, Tampa FL, Rochester MN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06090539

Phase 1, Phase 2, Recruiting

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

for
Psychosis Associated With Alzheimer's Disease
Location: Woodmere NY, Daytona Beach FL, Maitland FL, Clermont FL,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT05511363

Phase 3, Recruiting

Real-world Patient Reported Outcomes Among Patients Treated With Camzyos

for
Obstructive Hypertrophic Cardiomyopathy
Location: Boston MA
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06551129

Recruiting

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

for
Schizophrenia
Location: West Palm Beach FL, Hollywood FL, Atlanta GA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 18 - 65

Code: NCT07686263

Phase 3, Recruiting

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

for
Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy
Location: Lawrenceville NJ
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 0+

Code: NCT07732907

Recruiting

Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants

for
Healthy Volunteers
Location: Lincoln NE
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 55

Code: NCT07629999

Phase 1, Recruiting

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

for
Advanced Malignant Tumors
Location: Quebec, Hackensack NJ, Germantown TN, Vancouver
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06764771

Phase 1, Recruiting

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

for
Refractory Autoimmune Diseases
Location: Boston MA, Durham NC
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT07115745

Phase 1, Recruiting

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

for
Psychosis Associated With Alzheimer's Disease
Location: Stuart FL, Viera FL, Cypress TX
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT06126224

Phase 3, Recruiting

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

for
Lymphoma
Location: Boston MA, New York NY, New Brunswick NJ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT07015242

Phase 2, Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Quebec, Westbury NY, New York NY, Montreal, Norfolk VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361497

Phase 3, Recruiting